The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
Open accessPublished version of a preprint
Abstract
The COVID-19 pandemic has had an unprecedented health and economic impact and there are currently no approved therapies. We have isolated an antibody, EY6A, from an individual convalescing from COVID-19 and have shown that it neutralizes SARS-CoV-2 and cross-reacts with SARS-CoV-1. EY6A Fab binds the receptor binding domain (RBD) of the viral spike glycoprotein tightly (K D of 2 nM), and a 2.6-Å-resolution crystal structure of an RBD-EY6A Fab complex identifies the highly conserved epitope, away from the ACE2 receptor binding site. Residues within this footprint are key to stabilizing the pre-fusion spike. Cryo-EM analyses of the pre-fusion spike incubated with EY6A Fab reveal a complex of the intact spike trimer with three Fabs bound and two further multimeric forms comprising the destabilized spike attached to Fab. EY6A binds what is probably a major neutralizing epitope, making it a candidate therapeutic for COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Structures of WT RBD-EY6A-222 and the P.1 RBD-ACE2 complexes were determined by molecular replacement with PHASER (McCoy et al., 2007) using search models of SARS-CoV-2 RBD-EY6A-H4 (PDB ID 6ZCZ) (Zhou et al., 2020) and RBD-158 (PDB ID, 7BEK) (Dejnirattisai et al., 2021) complexes, and a RBD and ACE2 complex (PDB ID, 6LZG; Wang et al., 2020), respectively.”
From Antibody evasion by the P.1 strain of SARS-CoV-2 (2021) · cites this paper as Zhou et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Punjani, A., Rubinstein, J. L., Fleet, D. J., & Brubaker, M. A. (2017) · Nature Methods · doi:10.1038/nmeth.4169 · Cited by 11,626
Inference of Macromolecular Assemblies from Crystalline State
Krissinel, E., & Henrick, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.022 · Cited by 9,984
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586 · cited 9×
“RBD, ACE2, Spike ectodomain and CR3022 cloning Constructs are as described by Huo et al12.”
InfluentialREFMAC 5 for the refinement of macromolecular crystal structures
Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F., & Vagin, A. A. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911001314 · Cited by 8,317
Liebschner, D., Afonine, P. V., Baker, M. L., Bunkóczi, G., Chen, V. B., Croll, T. I., Hintze, B., Hung, L.-W., Jain, S., McCoy, A. J., et al. (2019) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798319011471 · Cited by 7,953
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K., Bleicker, T., Brünink, S., Schneider, J., Schmidt, M. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.3.2000045 · Cited by 7,344
Cited by
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Barnes, C. O., Jette, C. A., Abernathy, M. E., Dam, K.-M. A., Esswein, S. R., Gristick, H. B., Malyutin, A. G., Sharaf, N. G., Huey-Tubman, K. E., Lee, Y. E., et al. (2020) · Nature · doi:10.1038/s41586-020-2852-1 · Cited by 1,599
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Zhou, D., Dejnirattisai, W., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H. M. E., Tuekprakhon, A., Nutalai, R., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.037 · Cited by 992
Self-citationSARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Dejnirattisai, W., Huo, J., Zhou, D., Zahradník, J., Supasa, P., Liu, C., Duyvesteyn, H. M. E., Ginn, H. M., Mentzer, A. J., Tuekprakhon, A., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.046 · Cited by 930
“The binding of EY6A to the left flank of the RBD is essentially unchanged from that observed previously (Zhou et al., 2020) (dissociation constant [KD] 7.”
InfluentialSelf-citationAntibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Tuekprakhon, A., Nutalai, R., Dijokaite-Guraliuc, A., Zhou, D., Ginn, H. M., Selvaraj, M., Liu, C., Mentzer, A. J., Supasa, P., Duyvesteyn, H. M. E., et al. (2022) · Cell · doi:10.1016/j.cell.2022.06.005 · Cited by 686
Self-citationAntibody evasion by the P.1 strain of SARS-CoV-2
Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H. M. E., Tuekprakhon, A., Nutalai, R., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.055 · Cited by 583
“All crystals also contained a further Fab, EY6A, as a crystallization chaperone (Zhou et al., 2020) and were isomorphous, and the resolution of the structures ranged from 1.”
Self-citation
Metadata
- Authors
- Zhou, D., Duyvesteyn, H. M. E., Chen, C.-P., Huang, C.-G., Chen, T.-H., Shih, S.-R., Lin, Y.-C., Cheng, C.-Y., Cheng, S.-H., Huang, Y.-C., Lin, T.-Y., Ma, C., Huo, J., Carrique, L., Malinauskas, T., Ruza, R. R., Shah, P. N. M., Tan, T. K., Rijal, P., Donat, R. F., Godwin, K., Buttigieg, K. R., Tree, J. A., Radecke, J., Paterson, N. G., Supasa, P., Mongkolsapaya, J., Screaton, G. R., Carroll, M. W., Gilbert-Jaramillo, J., Knight, M. L., James, W., Owens, R. J., Naismith, J. H., Townsend, A. R., Fry, E. E., Zhao, Y., Ren, J., Stuart, D. I., & Huang, K.-Y. A.
- Affiliations
- Centre for Human Genetics (GB)
- Ministry of Health and Welfare (TW)
- Chang Gung University (TW)
- Genomics Research Center, Academia Sinica (TW)
- Tao Yuan General Hospital (TW)
- Chang Gung Memorial Hospital (TW)
- John Radcliffe Hospital (GB)
- Public Health England (GB)
- Diamond Light Source (GB)
- Siriraj Hospital (TH)
- University of Oxford (GB)
- Corresponding author
- Stuart, David I.
- Huang, Kuan-Ying A.
- ORCID
- Zhou, Daming
- Duyvesteyn, Helen M. E.
- Chen, Cheng-Pin
- Huang, Chung-Guei
- Chen, Ting-Hua
- Shih, Shin-Ru
- Lin, Yi-Chun
- Cheng, Chien-Yu
- Cheng, Shu-Hsing
- Huang, Yhu-Chering
- Lin, Tzou-Yien
- Ma, Che
- Huo, Jiandong
- Malinauskas, Tomas
- Ruza, Reinis R.
- Shah, Pranav N. M.
- Tan, Tiong Kit
- Rijal, Pramila
- Donat, Robert F.
- Buttigieg, Karen R.
- Tree, Julia A.
- Radecke, Julika
- Paterson, Neil G.
- Supasa, Piyada
- Mongkolsapaya, Juthathip
- Screaton, Gavin R.
- Carroll, Miles W.
- Gilbert-Jaramillo, Javier
- Knight, Michael L.
- James, William
- Owens, Raymond J.
- Naismith, James H.
- Townsend, Alain R.
- Fry, Elizabeth E.
- Zhao, Yuguang
- Ren, Jingshan
- Stuart, David I.
- Huang, Kuan-Ying A.
- Venue
- Nature Structural & Molecular Biology
- Published
- 2020-07-31
- Volume
- 27
- Issue
- 10
- Pages
- 950-958
- ISSN
- 1545-9985 (ISSN-L)
- 1545-9993
- OpenAlex
- W3046621022
- Cited by
- 274
- References
- 53
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 17 · 2023: 27 · 2022: 69 · 2021: 118 · 2020: 23
- FWCI
- 7.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Structural & Molecular Biology (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Ministry of Health and Welfare
- Wellcome Trust (2018-I2M-2-002, EP/S025243/1, 095541, 101122, 101122/Z/13/Z, 090532, 095541/A/11/Z, 100209/A/12/Z, 090532/Z/09/Z, 090532/Z/09/, 090532/Z)
- Diamond Light Source
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- Fast Grants
- Cancer Research UK (A14414, C20724 / A26752, 26752, A17721, C375/A17721, A26752, C20724/A14414, C20724)
- National Institute for Health and Care Research (COVID-19, 090532/Z/09/Z., 095541/A/11/Z)
- University of Oxford (090532/Z/09/Z)
- Chang Gung University
- Chang Gung Medical Foundation
- Chinese Academy of Medical Sciences (090532/Z/09/Z, 2018‐I2M‐2‐002)
- Centers for Disease Control and Prevention
- Tao Yuan General Hospital, Ministry of Health and Welfare
- Medical Research Council (MR/N00065X/1, MR/V001329/1, 095541/A/11/Z, 090532/Z09/Z, 2018-I2M-2-002, C375/A17721, COVID-19, 101122/Z/13/Z)
- Engineering and Physical Sciences Research Council (EP/S025243/1)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- SARS-CoV-2, neutralizing antibodies, receptor binding domain, spike protein, crystal structure, spike trimer, epitope mapping, CR3022, COVID-19 treatment
- MeSH terms
- Protein Domains, Betacoronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Adult, Animals, Antibodies, Viral, Epitopes, Binding Sites, Chlorocebus aethiops, Cross Reactions, Humans, Immunoglobulin Fab Fragments, Peptidyl-Dipeptidase A, Male, Pneumonia, Viral, Protein Conformation, Vero Cells, Coronavirus Infections, Crystallography, X-Ray, Cryoelectron Microscopy, Antibodies, Neutralizing, Pandemics, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient. https://app.cochat.ai/papers/10.1038/s41594-020-0480-y
- The paper
- Zhou, D., Duyvesteyn, H. M. E., Chen, C.-P., Huang, C.-G., Chen, T.-H., Shih, S.-R., Lin, Y.-C., Cheng, C.-Y., Cheng, S.-H., Huang, Y.-C., Lin, T.-Y., Ma, C., Huo, J., Carrique, L., Malinauskas, T., Ruza, R. R., Shah, P. N. M., Tan, T. K., Rijal, P., . . . Huang, K.-Y. A. (2020). Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient. Nature Structural & Molecular Biology. https://doi.org/10.1038/s41594-020-0480-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.